Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity (Tables)

v3.21.1
Stockholders' equity (Tables)
9 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of warrants or rights
The activity related to warrants during for the three and nine months ended March 31, 2021, is summarized as follows:
 
     Common Stock
from Warrants
     Weighted-
average
Exercise Price
(per share)
 
Outstanding at July 1, 2020
     145,424      $ 29.48  
Granted
     —          —    
Exercised
     —          —    
Forfeited
     (38,326      82.50  
    
 
 
    
 
 
 
Outstanding and exercisable at September 30, 2020
     107,098      $ 10.50  
Granted
     559,162        3.09  
Exercised
     (281,581      3.10  
Forfeited
     —          —    
    
 
 
    
 
 
 
Outstanding and exercisable at December 31, 2020
     384,679      $ 5.15  
Granted
     —          —    
Exercised
     (277,581      3.10  
Forfeited
     —          —    
    
 
 
    
 
 
 
Outstanding and exercisable at March 31, 2021
     107,098      $ 10.50  
    
 
 
    
 
 
 
Schedule of equity awards
The activity related to equity awards, which comprised of stock options during the three and nine months ended March 31, 2021, is summarized as follows:
 
     Stock
Options
     Weighted-
average
Exercise
Price
     Weighted-
average
Remaining
Contractual Term
     Aggregate
Intrinsic Value
 
Outstanding at June 30, 2020
     70,154      $ 60.42        2.89 years      $ —    
Granted
     —          —                      
Exercised
     —          —                      
Forfeited
     (444      69.32                    
    
 
 
    
 
 
                   
Outstanding at September 30, 2020
     69,710      $ 60.00        2.65 years        —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Granted
     525,547        2.98        9.95 years           
Exercised
     —          —                      
Forfeited
     (7,967      153.78                    
    
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding at December 31, 2020
     587,290        7.64        9.2 years        —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding at March 31, 2021
     587,290        7.64        8.9 years        —    
Exercisable at March 31, 2021
     41,686      $ 47.34        2.3 years      $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of share-basedcompensation expense
The classification of share-based compensation expense is summarized as follows:
 
    
Three Months Ended

March 31,
    
Nine Months Ended

March 31,
 
(US$’000)
  
2021
    
2020
    
2021
    
2020
 
Research and development
   $ 18      $ 18      $ 33      $  53  
General and administrative
     217        70        322        127  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total share-based compensation expense
   $ 235      $ 88      $ 355      $ 180